Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 9;19(2):1909-1916.
doi: 10.1007/s40200-020-00629-7. eCollection 2020 Dec.

Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis

Affiliations
Review

Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis

Nader Salari et al. J Diabetes Metab Disord. .

Abstract

Backgroud: Prevalence of skin lesions among diabetic patients is a major health concern. Therefore, this systematic review and meta-analysis study was conducted to determine the prevalence of skin lesions in diabetic patients.

Methods: To identify and select relevant articles, the SID, MagIran, IranMedex, IranDoc, Google Scholar, Cochrane, Embase, ScienceDirect, Scopus, PubMed, and Web of Science (WoS) databases were searched without a lower time limit and until April 2020. The random effects model was used to perform the analysis, and the heterogeneity of studies was assessed using the I2 index. Data were analyzed within the Comprehensive Meta-Analysis (Version 2) software.

Results: After evaluating the 22 final articles with a total sample size of 8406, the prevalence of skin lesions among diabetes patients were found as 70.3% (95% CI: 63-76.7%). Moreover, according to the meta-regression analysis, the effect of 'sample size' on th prevalence of skin lesions was significantly different in diabetes patients (p < 0.05).

Conclusion: The results of this study show that skin lesions are common in diabetes patients. Therefore, appropriate policies needs to be adopted to improve the situation and to monitor patients and outcomes at all levels.

Keywords: Diabetes; Meta-analysis; Prevalence; Skin lesions.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram for the study selection
Fig. 2
Fig. 2
Funnel plot results for the prevalence of skin lesions among diabetic patients
Fig. 3
Fig. 3
Prevalence of skin lesions in diabetic patients based on the randomized model
Fig. 4
Fig. 4
Meta-regression association between sample size and prevalence of skin lesions among diabetic patients
Fig. 5
Fig. 5
Meta-regression of association between year of study and prevalence of skin lesions among diabetic patients

References

    1. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ. Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol. 2006;106(1):1–28. doi: 10.1016/j.jep.2006.03.021. - DOI - PubMed
    1. Wild SH, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030: response to Rathman and Giani. Diabetes care. 2004;27(10):2569. doi: 10.2337/diacare.27.10.2569-a. - DOI - PubMed
    1. Echouffo-Tcheugui JB, Dagogo-Jack S. Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol. 2012;8(9):557–562. doi: 10.1038/nrendo.2012.46. - DOI - PubMed
    1. Ferinkel R, Freinkel N. Cutaneous manifestations of endocrine diseases. u: Fitzpatrick TB i dr.[ur.]. Dermatology in general medicine, New York, itd: McGraw-Hill. 1993:2113–31.
    1. Sibbald RG, Schachter RK. The skin and diabetes mellitus. Int J Dermatol. 1984;23(9):567–584. doi: 10.1111/j.1365-4362.1984.tb05694.x. - DOI - PubMed

LinkOut - more resources